Migraine Newswire (Page 5)

Migraine Newswire (Page 5)

Comprehensive Real-Time News Feed for Migraine. (Page 5)

Results 81 - 100 of 2,541 in Migraine

  1. Breaking the cycleRead the original story w/Photo

    Feb 18, 2017 | Denton Record-Chronicle

    ... Argyle, is a sports and pain board-certified physician who specializes in interventional concussion management and migraine treatment. He originally took interest in the device as a quick, minimally invasive way to treat patients with chronic ...

    Comment?

  2. The frightening reality of VRRead the original story

    Feb 16, 2017 | Marketing

    ... away, using VR for educational value or personal betterment. Headache remedy Excedrin has used the tech to simulate migraine symptoms to build empathy among non-migraine sufferers, and HA agen-Dasz lets users see the world through the eyes of bees. ...

    Comment?

  3. Botox now available on prescription for NHS ScotlandRead the original story w/Photo

    Feb 14, 2017 | Evening Times

    ... the injections are estimated at A 119,000 in the first year rising to A 335,000. The decision to approve Botox for migraine treatment brings Scotland into line with the rest of the UK, and comes after two previous rejections by the SMC. Migraine ...

    Comment?

  4. Botox to be prescribed on NHS in Scotland for migraine patientsRead the original story w/Photo

    Feb 13, 2017 | Sunday Herald

    ... the injections are estimated at A 119,000 in the first year rising to A 335,000. The decision to approve Botox for migraine treatment brings Scotland into line with the rest of the UK, and comes after two previous rejections by the SMC. Migraine ...

    Comment?

  5. People's Pharmacy: Hormone treatment may not be needed after menopauseRead the original story w/Photo

    Feb 13, 2017 | Athens Banner-Herald

    ... exercise. It remains just slightly too high for everyone's comfort, and seems to spike when I take sumatriptan for migraine. I am concerned about metoprolol. Is it safe, and will it really help me with both migraine and BP? I really do not want to ...

    Comment?

  6. Zosana Pharma's stock rockets after migraine patch produces positive trial resultsRead the original story w/Photo

    Feb 13, 2017 | MarketWatch

    Volume spiked to 12.4 million shares, compared with the full-day average of about 268,000 shares. Zosana said a trial of its lead candidate, M207, which is a patch used to treatment migraine pain, achieved both co-primary endpoints of pain freedom and most-bothersome-symptom freedom in a phase 3 trial.

    Comment?

  7. Better Buy: Amgen Inc. vs. CelgeneRead the original story w/Photo

    Feb 8, 2017 | Fox News

    ... promising new late-stage candidates with experimental osteoporosis drug romosozumab and erenumab, an experimental migraine drug in development in collaboration with Novartis . No one can complain about Amgen's financial position. The company is one ...

    Comment?

  8. Pain Therapeutics - Drugs, Markets & Companies - Analyzed for the...Read the original story

    Feb 8, 2017 | Customer Interaction Solutions

    ... Various pain syndromes require different approaches in management, for example, the main category of drugs for migraine are triptans such as sumatriptan. Drug delivery is an important consideration in pain treatment. Controlled release preparations ...

    Comment?

  9. Healthwise: Hope for migraine sufferersRead the original story w/Photo

    Feb 6, 2017 | The Day

    ... has brought on this angst? Tension? Stress? Chances are, if you are living with this type of pain, you are having a migraine headache. You head hurts so much, there seems to be no relief in sight. A migraine is a type of headache which is intense ...

    Comment?

  10. Former teacher sues Canberra Hospital, doctors over alleged failures stemming from migraine treatmentRead the original story w/Photo

    Feb 6, 2017 | Sydney Morning Herald

    ... a dozen lawyers and barristers and a packed public gallery in the ACT Supreme Court. Ms Cave had been taking the migraine drug Deseril since the late 1990s, prescribed by Woden general practitioner Dr Brenda Jean Tait and a consulting neurologist. ...

    Comment?

  11. New Zealand fines pharmaceutical firmRead the original story

    Feb 3, 2017 | Nerve News

    ... New Zealand Commerce Commission. The Nurofen products in question were marketed separately as analgesics to treat migraine, back pain, menstrual pain and stress-induced headaches though they all contained the same active ingredient - 342 mg of ...

    Comment?

  12. Advances in models for early prediction of migraine and other chronic conditionsRead the original story w/Photo

    Feb 2, 2017 | PhysOrg Weblog

    ... drug intake, thus preventing or lessening pain. The methodology could also be used for other chronic diseases . Migraine is a primary headache disorder that affects around 15 percent of the European population and generates high costs to public and ...

    Comment?

  13. The University Pain Medicine Center Offers Relief for Individuals with Snow Shoveling InjuriesRead the original story w/Photo

    Feb 2, 2017 | SBWire

    ... and more. In addition to back injuries, the University Pain Medicine Center is also able to provide headache and migraine treatment to patients in Franklin Township, NJ and the surrounding communities. People commonly experience headaches for a ...

    Comment?

  14. When sleeping in separate rooms could save your marriageRead the original story w/Photo

    Jan 28, 2017 | Vanguard

    ... s and neck for five minutes to relieve any tension, is sufficient." Similarly, keeping a diary can help to identify migraine triggers and avoid

    Comment?

  15. Redhill Biopharma Ltd. (RDHL) Raised to Buy at Zacks Investment ResearchRead the original story w/Photo

    Jan 25, 2017 | Daily Political

    Zacks Investment Research currently has $12.00 price target on the stock. According to Zacks, "RedHill Biopharma focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases, including cancer.

    Comment?

  16. Can Acorda Therapeutics Inc (ACOR) Give Eli Lilly And Co (LLY) A Run...Read the original story w/Photo

    Jan 24, 2017 | Insider Monkey

    ... free by clicking here or you can login if you are already a member. Acorda Therapeutics Inc (NASDAQ: ACOR ) inhaled migraine candidate CVT-427 is seen by Janney analyst Ken Trbovich as likely to give Eli Lilly and Co (NYSE: LLY ) severe competition ...

    Comment?

  17. Allergan Release: Pharma Continues Commitment To Future Of Headache...Read the original story

    Jan 22, 2017 | BioSpace

    ... potential drug targets, emerging new treatments, and the importance of patient advocacy. , Chair of the American Migraine Foundation and President of the International Headache Society. "We are inspired by our attendees' commitment to raising their ...

    Comment?

  18. Week In Review: WuXi AppTec Acquires HD Biosciences In China CRO TieupRead the original story w/Photo

    Jan 22, 2017 | Seeking Alpha

    ... formed a partnership with Switzerland's Applied Pharma Research to distribute Diclofenac, a patented treatment for migraine, in China, Hong Kong, Macao and Taiwan. APR's product is a powder for oral solution. So far, migraines are not a major ...

    Comment?

  19. Eli Lilly: How Does The CoLucid Deal Impact The Stock?Read the original story w/Photo

    Jan 20, 2017 | Seeking Alpha

    ... Lilly currently has emerging pain pipeline assets including galcanezumab , which offers prospective treatment for migraine and cluster headache. CoLucid's main promise lies in its oral migraine medication, lasmiditan , which could be near the point ...

    Comment?

  20. Redhill Bio-Adr (RDHL) Upgraded to Buy by Zacks Investment ResearchRead the original story w/Photo

    Jan 20, 2017 | IntersportsWire

    They currently have $12.00 price target on the stock. According to Zacks, "RedHill Biopharma focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases, including cancer.

    Comment?